Guardant Health Inc

NASDAQ:GH   3:59:51 PM EDT
-1.22 (-1.55%)
Products, Litigation

Guardant Health And Foundation Medicine Reach Settlement In Digital Sequencing Technology Litigation

Published: 01/07/2022 22:37 GMT
Guardant Health Inc (GH) - Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technology Litigation.
Guardant Health - Foundation Medicine to Pay Co $25 Million & Future Royalties for Remaining Term of Licensed Digital Sequencing Technology Patents.
Guardant Health - As a Result of This Settlement, All Pending Patent Litigation Between Foundation Medicine and Guardant Health Will Be Dismissed.
Guardant Health - Will Grant Foundation Medicine a Non-exclusive License to a Defined Subset of Its Digital Sequencing Technology Patents.